Literature DB >> 25842274

The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men.

Zacharias Mandalenakis1, Lotta Von Koch2, Henry Eriksson2, Mikael Dellborg2, Kenneth Caidahl3, Lennart Welin2, Annika Rosengren2, Per-Olof Hansson2.   

Abstract

AIM: This study aimed to estimate the prevalence, incidence rate, and lifetime risk of developing atrial fibrillation (AF) in a population-based study of Swedish men. METHODS AND
RESULTS: The study is a part of 'The Study of Men Born in 1913', which is a longitudinal prospective cohort study of 855 men born in 1913 and living in the city of Gothenburg in Sweden. They were followed from the age of 50 years until 98 years with repeated examinations and data from the Swedish National Hospital Discharge Register. A total of 185 (21.6%) men developed AF. The prevalence of AF increased from 0.4% at 50 years old, to 1.9% by 60 years old, to 4.6% by 70 years old, to 12.5% by 80 years old, and to 15.7% by 90 years old. The lifetime risk of developing AF was 22.5%.
CONCLUSION: Atrial fibrillation is rare at the age of 50 in Swedish men, but it increases exponentially with age, markedly accelerating after 70 years old. In nonagenarians, one of five men has or has had AF. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; Incidence; Lifetime risk; Population-based studies; Prevalence

Mesh:

Year:  2015        PMID: 25842274     DOI: 10.1093/europace/euv036

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  11 in total

1.  Use of Direct-Acting Oral Anticoagulants in Nonagenarians: A Call for More Data.

Authors:  Claudia Stöllberger; Roman Brooks; Josef Finsterer; Thomas Pachofszky
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

2.  Atrial Fibrillation and the Risk of Subsequent Fracture.

Authors:  Jason A Sherer; Qiuxi Huang; Douglas P Kiel; Emelia J Benjamin; Ludovic Trinquart
Journal:  Am J Med       Date:  2020-03-05       Impact factor: 4.965

3.  Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.

Authors:  Lu-Chen Weng; Sarah R Preis; Olivia L Hulme; Martin G Larson; Seung Hoan Choi; Biqi Wang; Ludovic Trinquart; David D McManus; Laila Staerk; Honghuang Lin; Kathryn L Lunetta; Patrick T Ellinor; Emelia J Benjamin; Steven A Lubitz
Journal:  Circulation       Date:  2017-11-12       Impact factor: 29.690

4.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).

Authors:  Christina Magnussen; Teemu J Niiranen; Francisco M Ojeda; Francesco Gianfagna; Stefan Blankenberg; Inger Njølstad; Erkki Vartiainen; Susana Sans; Gerard Pasterkamp; Maria Hughes; Simona Costanzo; Maria Benedetta Donati; Pekka Jousilahti; Allan Linneberg; Tarja Palosaari; Giovanni de Gaetano; Martin Bobak; Hester M den Ruijter; Ellisiv Mathiesen; Torben Jørgensen; Stefan Söderberg; Kari Kuulasmaa; Tanja Zeller; Licia Iacoviello; Veikko Salomaa; Renate B Schnabel
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

5.  Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.

Authors:  Laila Staerk; Biqi Wang; Kathryn L Lunetta; Robert H Helm; Darae Ko; Jason A Sherer; Patrick T Ellinor; Steven A Lubitz; David D McManus; Ramachandran S Vasan; Emelia J Benjamin; Ludovic Trinquart
Journal:  J Am Heart Assoc       Date:  2017-11-14       Impact factor: 5.501

6.  Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Liping Mou; Faye L Norby; Lin Y Chen; Wesley T O'Neal; Tené T Lewis; Laura R Loehr; Elsayed Z Soliman; Alvaro Alonso
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-07

7.  Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.

Authors:  Menno V Huisman; Chang Sheng Ma; Hans-Christoph Diener; Sergio J Dubner; Jonathan L Halperin; Kenneth J Rothman; Christine Teutsch; Nils Schoof; Eva Kleine; Dorothee B Bartels; Gregory Y H Lip
Journal:  Europace       Date:  2016-06-21       Impact factor: 5.214

8.  DietaryFish and Long-Chain n-3 Polyunsaturated Fatty Acids Intake and Risk of Atrial Fibrillation: A Meta-Analysis.

Authors:  Fu-Rong Li; Guo-Chong Chen; Jiabi Qin; Xianbo Wu
Journal:  Nutrients       Date:  2017-08-29       Impact factor: 5.717

9.  Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.

Authors:  Laila Staerk; Biqi Wang; Sarah R Preis; Martin G Larson; Steven A Lubitz; Patrick T Ellinor; David D McManus; Darae Ko; Lu-Chen Weng; Kathryn L Lunetta; Lars Frost; Emelia J Benjamin; Ludovic Trinquart
Journal:  BMJ       Date:  2018-04-26

10.  Change in lipid profile and risk of new-onset atrial fibrillation in patients with chronic heart failure: A 3-year follow-up observational study in a large Chinese hospital.

Authors:  Chen Liu; Jin Geng; Xiao Ye; Xiaochen Yuan; Aihua Li; Zhengang Zhang; Biao Xu; Yingwei Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.